Literature DB >> 2679494

Enhancement of exogenous triglyceride removal following calcium channel blockade.

T Marotta1, L A Ferrara, F Pasanisi, P Rubba, C Iovine, M Mancini.   

Abstract

Adrenergic regulation of lipid metabolism is mediated by various intracellular messengers, including calcium ions. Little is known about the role of calcium in the catabolism of triglyceride-rich lipoproteins. Aim of this study was to investigate whether blockade of calcium influx across the cell membrane influences lipid metabolism in man. The calcium entry blocker nitrendipine was administered to 10 hypertensive, normolipidemic subjects for eight weeks at the dose of 10 mg b.i.d. An enhancement in plasma clearance of triglyceride was observed after nitrendipine administration: fractional removal rate of the triglyceride emulsion Intralipid increased by 22% (from 3.13 +/- 1.1 after placebo to 3.81 +/- 1.4% min after nitrendipine, p less than 0.03). Fasting serum triglyceride was not shifted (83 +/- 57 vs 84 +/- 37 mg/dl). Total serum cholesterol and cholesterol in high density lipoproteins were also unchanged during the study. No evidence of change in insulin response was detected. It is hypothesized that calcium plays a role in the modulation of lipoprotein lipase, the enzyme mainly responsible of the removal of exogenous triglyceride from plasma. Alternatively, the increase in the clearance rate of the triglyceride emulsion might be explained by the vasodilating activity of nitrendipine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679494

Source DB:  PubMed          Journal:  Artery        ISSN: 0098-6127


  3 in total

1.  Evaluation of lipid metabolism during antihypertensive treatment with nicardipine sr.

Authors:  F Pasanisi; T Marotta; L A Ferrara; O Russo; M Mancini
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Metabolic effects of lacidipine: a placebo-controlled study using the euglycaemic hyperinsulinaemic clamp.

Authors:  A D Morris; R Donnelly; J M Connell; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

3.  Effect of lacidipine, a long-acting calcium antagonist, on hypertension and lipids: a 1 year follow-up.

Authors:  S Soro; L A Ferrara
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.